https://milmedunico.com/new-patent-application-filed/2022-05-17T14:52:16+02:00https://milmedunico.com/production-agreement-signed-with-orkla/2021-10-28T09:31:49+02:00https://milmedunico.com/agreement-signed-with-professor-archer/2021-10-28T09:32:13+02:00https://milmedunico.com/new-agreement-with-sapienza-university/2021-10-28T09:32:30+02:00https://milmedunico.com/report-from-study-of-toxicity/2021-10-28T09:32:26+02:00https://milmedunico.com/results-from-in-vitro-study/2021-10-28T09:32:21+02:00https://milmedunico.com/patent-application-filed/2021-10-28T09:32:17+02:00https://milmedunico.com/scientific-article-published/2021-10-28T09:32:08+02:00https://milmedunico.com/international-patent-application-filed/2021-10-28T09:32:04+02:00https://milmedunico.com/published-scientific-article/2021-10-28T09:31:59+02:00https://milmedunico.com/allergy-patent-approved/2021-10-28T09:31:54+02:00https://milmedunico.com/doctor-anders-milton-becomes-new-chairman-for-milmed-unico-ab/2022-05-18T22:50:53+02:00https://milmedunico.com/physiologic-and-subjective-health-benefits-of-milmed-among-racehorses-in-training/2022-05-17T15:42:23+02:00https://milmedunico.com/milmed-unico-abs-ceo-thomas-lenz-participates-at-swiss-nordic-bio-zurich/2022-05-17T15:39:49+02:00https://milmedunico.com/milmed-unico-abs-ceo-thomas-lenz-participates-at-pharmabiotics-2022-lyon/2022-05-17T15:41:01+02:00https://milmedunico.com/member-of-sweden-bio/2022-08-10T21:29:01+02:00https://milmedunico.com/new-patent-application/2022-08-10T21:30:30+02:00https://milmedunico.com/new-article/2022-09-14T23:08:46+02:00https://milmedunico.com/milmed-unico-broadens-its-competence-with-anna-linton/2022-09-19T22:35:58+02:00https://milmedunico.com/bio-europe-october-2022-leipzig/2022-10-30T18:21:32+01:00https://milmedunico.com/patent-approval-inflammatory-diseases/2022-11-20T08:40:02+01:00https://milmedunico.com/pharmabiotics-conference-in-lyon-21-22-march-2023/2023-03-27T18:55:45+02:00https://milmedunico.com/6th-biotech-hanse-forum-in-stockholm-on-tuesday-18/2025-01-22T22:21:31+01:00https://milmedunico.com/new-patent-application-submitted/2025-01-22T22:25:55+01:00https://milmedunico.com/milmed-unicos-new-subsidiary-longevience-ab-is-registred/2025-01-22T22:28:50+01:00https://milmedunico.com/trevor-archer-and-thomas-lenz-has-participated-in-the-30th-annual-bio-europe/2025-01-22T22:31:50+01:00https://milmedunico.com/visit-to-sapienza-university/2025-01-22T22:33:39+01:00https://milmedunico.com/new-trademark-is-approved/2025-01-22T22:34:50+01:00https://milmedunico.com/new-production-is-being-produced-by-jastbolaget/2025-01-22T22:36:36+01:00https://milmedunico.com/new-agreement-signed/2025-01-22T22:37:41+01:00https://milmedunico.com/thomas-lenz-participated-in-the-the-ipa-world-congress-probiota-2025/2025-02-10T19:35:08+01:00https://milmedunico.com/a-new-milmed-article-is-published-in-the-highly-ranked-mdpi-journal/2025-03-30T17:19:07+02:00https://milmedunico.com/ageviva-webshop/2025-09-12T07:56:42+02:00https://milmedunico.com/the-last-results-obtained-by-sapienza-team-during-first-half-of-2025/2025-09-12T08:01:27+02:00https://milmedunico.com/the-aging-research-drug-discovery-symposium-in-copenhagen-25-29-august/2025-09-12T08:03:57+02:00https://milmedunico.com/new-distribution-agreement-signed-with-german-pharma-company/2025-12-09T08:45:50+01:00